What is the price target for CPAY stock?
22 analysts have analysed CPAY and the average price target is 389.81 USD. This implies a price increase of 25.11% is expected in the next year compared to the current price of 311.57.
NYSE:CPAY • US2199481068
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CORPAY INC (CPAY).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-31 | Baird | Maintains | Outperform -> Outperform |
| 2026-02-10 | UBS | Maintains | Neutral -> Neutral |
| 2026-02-09 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2026-02-06 | Mizuho | Maintains | Neutral -> Neutral |
| 2026-02-05 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2026-02-05 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-02-05 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2026-01-27 | Cantor Fitzgerald | Initiate | Overweight |
| 2026-01-26 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2026-01-12 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-12-05 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2025-11-06 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-06 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-11-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-10-01 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-08-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-07 | UBS | Maintains | Neutral -> Neutral |
| 2025-08-07 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-07-17 | Deutsche Bank | Reiterate | Buy |
| 2025-05-07 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-07 | Raymond James | Reiterate | Outperform -> Outperform |
| 2025-04-28 | Oppenheimer | Initiate | Perform |
| 2025-04-24 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-14 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-06 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.758B 9.65% | 3.975B 5.77% | 4.528B 13.93% | 5.373B 18.65% | 5.935B 10.46% | 6.492B 9.39% | 7.064B 8.81% | 7.664B 8.49% | 8.267B 7.87% | 8.864B 7.22% | 9.448B 6.59% | |
| EBITDA YoY % growth | 1.993B 12.70% | 2.107B 5.69% | 2.345B 11.31% | 2.903B 23.79% | 3.232B 11.33% | 3.6B 11.39% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 1.657B 14.54% | 1.756B 5.97% | 1.952B 11.16% | 2.368B 21.32% | 2.777B 17.27% | 3.157B 13.68% | 3.373B 6.84% | 3.721B 10.32% | 4.08B 9.65% | 4.445B 8.95% | 4.814B 8.30% | |
| Operating Margin | 44.09% | 44.18% | 43.10% | 44.07% | 46.79% | 48.63% | 47.75% | 48.55% | 49.35% | 50.15% | 50.95% | |
| EPS YoY % growth | 16.92 5.09% | 19.01 12.35% | 21.38 12.47% | 26.42 23.59% | 30.27 14.56% | 35.03 15.71% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 5.55 23.10% | 6.34 23.63% | 7.06 23.91% | 7.43 23.01% | 6.55 17.93% | 7.32 15.45% | 7.99 13.16% | 8.43 13.42% | 7.38 12.71% | 8.48 15.83% | 9.27 15.94% | 9.73 15.47% |
| Revenue Q2Q % growth | 1.235B 22.80% | 1.316B 19.42% | 1.389B 18.47% | 1.432B 14.72% | 1.357B 9.88% | 1.453B 10.41% | 1.534B 10.44% | 1.599B 11.66% | 1.507B 11.05% | 1.591B 9.50% | 1.694B 10.43% | 1.734B 8.44% |
| EBITDA Q2Q % growth | 651.26M 25.41% | 713.25M 7.59% | 770.64M -3.65% | 799.82M -12.64% | 713.29M 9.52% | 785.97M 10.20% | 847.57M 9.98% | 888.55M 11.09% | 805.72M 12.96% | 883.04M 12.35% | 960.74M 13.35% | 988.28M 11.22% |
| EBIT Q2Q % growth | 531.21M 24.37% | 591.36M 23.36% | 647.7M 23.81% | 669.03M 28.11% | 587.05M 10.51% | 652.33M 10.31% | 707.89M 9.29% | 736.19M 10.04% | 646.24M 10.08% | 724.29M 11.03% | 800.88M 13.14% | 806.89M 9.60% |
All data in USD
22 analysts have analysed CPAY and the average price target is 389.81 USD. This implies a price increase of 25.11% is expected in the next year compared to the current price of 311.57.
CORPAY INC (CPAY) will report earnings on 2026-05-07, after the market close.
The consensus EPS estimate for the next earnings of CORPAY INC (CPAY) is 5.55 USD and the consensus revenue estimate is 1.24B USD.
The number of analysts covering CORPAY INC (CPAY) is 22.